Integrating use-error risk analysis into design reviews and DHF documentation Integrating use-error risk analysis into design reviews and DHF documentation The integration of use-error risk analysis into design reviews and Design History File (DHF) documentation is a critical aspect of Regulatory Affairs (RA) in the pharmaceutical and medical devices industries. Given the regulatory landscape in the US, EU, and UK, it is essential for Kharma professionals and others in RA to understand the guidelines and expectations set by regulatory agencies. This article provides a comprehensive overview of the regulatory context, legal basis, documentation requirements, review and approval workflows, and common…

Building robust use scenarios and task analyses for human factors studies Building robust use scenarios and task analyses for human factors studies Context Human factors and operator qualification are critical elements in the design and development of pharmaceutical products and medical devices. The primary goal is to optimize human interaction with systems to minimize the potential for use errors. Use-error risk analysis is a vital component of human factors studies, enabling the identification and mitigation of risks associated with the interaction between users and devices. As per regulatory guidelines, performing thorough use-error risk analyses and task mapping is essential to…

Prioritising critical-user steps for validation in high-risk device workflows Prioritising Critical-User Steps for Validation in High-Risk Device Workflows Context The role of Regulatory Affairs (RA) in the lifecycle of medical devices is paramount, especially when addressing high-risk workflows that involve the potential for use errors. Understanding use-error risk analysis, task mapping, and the identification of critical user steps is essential for ensuring compliance with regulatory expectations and safeguarding patient safety. This document provides a detailed examination of the relevant regulations, guidelines, and agency expectations applicable in the US, UK, and EU. Legal/Regulatory Basis The legal frameworks governing medical devices across…

Linking Use-Error Risk Analysis to Labeling, IFU, and Training Content Linking Use-Error Risk Analysis to Labeling, IFU, and Training Content In the ever-evolving landscape of pharmaceutical and medical device regulations, understanding how to effectively link use-error risk analysis to labeling, Instructions for Use (IFU), and training content is crucial. This article provides a comprehensive overview of the relevant regulations, guidelines, and agency expectations that inform the interaction between Regulatory Affairs (RA), Quality Assurance (QA), Quality Control (QC), and validation professionals in the context of human factors and operator qualification. Regulatory Context Human factors engineering and risk analysis are integral components…

Common mistakes in task mapping that lead to residual use-error risk Common mistakes in task mapping that lead to residual use-error risk Regulatory Affairs Context In the field of regulatory affairs, understanding and mitigating use-error risks is a paramount concern for both pharmaceutical and medical device professionals. As defined in ISO 14971, use-error refers to any unintended outcome that results from user’s misinterpretation or misuse of a product. These risks cannot be overlooked, especially given the potential regulatory and legal repercussions of product failures linked to human factors. Regulatory authorities in the US, UK, and EU emphasize the importance of…

Using hazard analysis tools to structure human factors risk discussions Using Hazard Analysis Tools to Structure Human Factors Risk Discussions Regulatory Affairs Context The integration of human factors into regulatory strategy is essential for pharmaceutical and medical device manufacturers. The systematic evaluation of use-error risk helps ensure that products are designed for optimal user interaction, thereby enhancing patient safety and product efficacy. Regulatory agencies such as the FDA, EMA, and MHRA emphasize the importance of understanding human factors to mitigate risks associated with use errors. This article presents a structured approach to use-error risk analysis grounded in relevant regulations, guidelines,…

Creating Traceability from Use-Error Risks to Design Requirements and Tests Creating Traceability from Use-Error Risks to Design Requirements and Tests Context In the regulatory landscape of pharmaceuticals and medical devices, use-error risk analysis is a critical component that ensures user safety and product efficacy. This structured, systematic approach identifies potential errors that users may encounter during the operation of a device or the administration of a drug product, thereby enabling organizations to mitigate risks effectively. As Kharma and regulatory professionals, understanding how to create traceability from identified use-error risks to design requirements and tests is essential. This article provides a…

Case Studies of Use-Error Driven Recalls and Lessons for Risk Analysis Case Studies of Use-Error Driven Recalls and Lessons for Risk Analysis In the pharmaceutical and medical device sectors, the emphasis on regulatory compliance and patient safety is paramount. As professionals navigate the intricacies of regulatory affairs, a comprehensive understanding of use-error risk analysis, task mapping, and critical user steps evolves as a crucial component. This article serves as a regulatory explainer manual to provide an in-depth exploration of case studies centered around use-error driven recalls, their implications on risk analysis, and the frameworks that guide these processes. Context of…

Templates and tools for documenting task mapping in human factors files Templates and tools for documenting task mapping in human factors files Human factors engineering (HFE) plays a critical role in ensuring the safety and efficacy of medical devices and pharmaceutical products. One of the key components of HFE is use-error risk analysis, which helps identify potential user errors associated with the use of a product, and subsequently mitigate those risks through effective design and validation processes. This article serves as a comprehensive guide for regulatory professionals regarding the essential templates and tools for documenting task mapping, a vital aspect…

Aligning use-error risk analysis with ISO 14971 and FDA expectations Aligning Use-Error Risk Analysis with ISO 14971 and FDA Expectations Effective regulatory affairs (RA) practices are crucial for ensuring the safety and efficacy of medical devices and pharmaceuticals. A significant aspect of RA is the evaluation of human factors and the potential for use errors that could compromise patient safety. This article aims to provide a comprehensive overview of the use-error risk analysis process, particularly when aligned with ISO 14971 and FDA expectations, including task mapping and the identification of critical user steps. Regulatory Context In the realm of regulatory…